Published in Healthcare Finance, Tax and Law Weekly, September 1st, 2004
These results include a previously announced pre-tax impairment charge of $9.5 million ($0.13 DEPS) related to the sale of the aquatic operations of the Animal Health business and charges of $1.9 million or ($0.03) DEPS related to the prepayment of debt. Excluding these items, DEPS for the quarter was $0.17.
The company exceeded its break even guidance for the quarter due to higher than expected income related to metformin hydrochloride extended release tablets (metformin ER) and stronger than anticipated performances in the company's Active...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.